Cargando…

Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice

BACKGROUND: Neuropsychiatric systemic lupus erythaematosus (NP-SLE) is one of the major manifestations of lupus. However, the mechanisms involved in NP-SLE are still largely unknown. The abnormal activation of the type I IFN signalling pathway is involved in SLE pathogenesis and is linked to NP-SLE,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zeng, Jing, Meng, Xinyu, Zhou, Ping, Yin, Zhihua, Xie, Qinglian, Zou, Hong, Shen, Nan, Ye, Zhizhong, Tang, Yuanjia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724270/
https://www.ncbi.nlm.nih.gov/pubmed/31481114
http://dx.doi.org/10.1186/s13075-019-1985-9
_version_ 1783448954940162048
author Zeng, Jing
Meng, Xinyu
Zhou, Ping
Yin, Zhihua
Xie, Qinglian
Zou, Hong
Shen, Nan
Ye, Zhizhong
Tang, Yuanjia
author_facet Zeng, Jing
Meng, Xinyu
Zhou, Ping
Yin, Zhihua
Xie, Qinglian
Zou, Hong
Shen, Nan
Ye, Zhizhong
Tang, Yuanjia
author_sort Zeng, Jing
collection PubMed
description BACKGROUND: Neuropsychiatric systemic lupus erythaematosus (NP-SLE) is one of the major manifestations of lupus. However, the mechanisms involved in NP-SLE are still largely unknown. The abnormal activation of the type I IFN signalling pathway is involved in SLE pathogenesis and is linked to NP-SLE, but the effect of IFN-α on NP-SLE encephalopathy has not been systematically studied. METHODS: An intravenous injection of Adv-IFN-α (10 mice, 10 × 10(9) vp) was administered to the IFN-α-treated group, and Adv-ctrl (10 mice, 10 × 10(9) vp) (ViGene Biosciences, China) was administered to the control group. Gene expression was determined by real-time quantitative polymerase chain reaction (RT-qPCR). Enzyme-linked immunosorbent assay (ELISA) was used to detect antibodies in the serum, and urinary protein levels were measured with a BCA Protein Assay kit. Haematoxylin-eosin (H&E) and periodic acid-Schiff (PAS)-light green staining were used for kidney histology. The elevated plus-maze test, novelty-suppressed feeding assay, open-field test, tail suspension test, social dominance tube test, three-chamber social interaction test, step-down passive avoidance test and novelty Y-maze task were used to assess behaviour. RESULTS: In this study, we performed a series of behavioural tests to assess the neuropsychiatric phenotypes of IFN-α-treated NZB/NZW F1 mice and found that these mice developed a series of mental disorders such as anxiety-like phenotypes, depression-like phenotypes, deficits in sociability and cognitive impairments, which mimic the neuropsychiatric manifestations of NP-SLE, with a consistent onset and progression. CONCLUSIONS: Our research verified that IFN-α plays a critical role in NP-SLE and provides a comprehensive NP-SLE mouse model for dissecting the mechanisms of NP-SLE and developing novel therapies for intervention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1985-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6724270
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-67242702019-09-10 Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice Zeng, Jing Meng, Xinyu Zhou, Ping Yin, Zhihua Xie, Qinglian Zou, Hong Shen, Nan Ye, Zhizhong Tang, Yuanjia Arthritis Res Ther Research Article BACKGROUND: Neuropsychiatric systemic lupus erythaematosus (NP-SLE) is one of the major manifestations of lupus. However, the mechanisms involved in NP-SLE are still largely unknown. The abnormal activation of the type I IFN signalling pathway is involved in SLE pathogenesis and is linked to NP-SLE, but the effect of IFN-α on NP-SLE encephalopathy has not been systematically studied. METHODS: An intravenous injection of Adv-IFN-α (10 mice, 10 × 10(9) vp) was administered to the IFN-α-treated group, and Adv-ctrl (10 mice, 10 × 10(9) vp) (ViGene Biosciences, China) was administered to the control group. Gene expression was determined by real-time quantitative polymerase chain reaction (RT-qPCR). Enzyme-linked immunosorbent assay (ELISA) was used to detect antibodies in the serum, and urinary protein levels were measured with a BCA Protein Assay kit. Haematoxylin-eosin (H&E) and periodic acid-Schiff (PAS)-light green staining were used for kidney histology. The elevated plus-maze test, novelty-suppressed feeding assay, open-field test, tail suspension test, social dominance tube test, three-chamber social interaction test, step-down passive avoidance test and novelty Y-maze task were used to assess behaviour. RESULTS: In this study, we performed a series of behavioural tests to assess the neuropsychiatric phenotypes of IFN-α-treated NZB/NZW F1 mice and found that these mice developed a series of mental disorders such as anxiety-like phenotypes, depression-like phenotypes, deficits in sociability and cognitive impairments, which mimic the neuropsychiatric manifestations of NP-SLE, with a consistent onset and progression. CONCLUSIONS: Our research verified that IFN-α plays a critical role in NP-SLE and provides a comprehensive NP-SLE mouse model for dissecting the mechanisms of NP-SLE and developing novel therapies for intervention. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s13075-019-1985-9) contains supplementary material, which is available to authorized users. BioMed Central 2019-09-03 2019 /pmc/articles/PMC6724270/ /pubmed/31481114 http://dx.doi.org/10.1186/s13075-019-1985-9 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Zeng, Jing
Meng, Xinyu
Zhou, Ping
Yin, Zhihua
Xie, Qinglian
Zou, Hong
Shen, Nan
Ye, Zhizhong
Tang, Yuanjia
Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
title Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
title_full Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
title_fullStr Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
title_full_unstemmed Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
title_short Interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
title_sort interferon-α exacerbates neuropsychiatric phenotypes in lupus-prone mice
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6724270/
https://www.ncbi.nlm.nih.gov/pubmed/31481114
http://dx.doi.org/10.1186/s13075-019-1985-9
work_keys_str_mv AT zengjing interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT mengxinyu interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT zhouping interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT yinzhihua interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT xieqinglian interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT zouhong interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT shennan interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT yezhizhong interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice
AT tangyuanjia interferonaexacerbatesneuropsychiatricphenotypesinlupuspronemice